Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
Total Valuation
ATAI Life Sciences has a market cap or net worth of $1.57B. The enterprise value is $1.04B.
Market Cap$1.57B
Enterprise Value$1.04B
Share Statistics
ATAI Life Sciences has 363,114,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding363,114,440
Owned by Insiders21.24%
Owned by Institutions1.77%
Financial Efficiency
ATAI Life Sciences’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -71.01%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.94
Return on Invested Capital (ROIC)-71.01%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee5.70K
Profits Per Employee-2.78M
Employee Count54
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ATAI Life Sciences is ―. ATAI Life Sciences’s PEG ratio is -0.00525.
PE Ratio―
PS Ratio691.60
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-2.58
Price to Operating Cash Flow-10.99
PEG Ratio-0.00525
Income Statement
In the last 12 months, ATAI Life Sciences had revenue of 308.00K and earned -149.27M in profits. Earnings per share was -0.93.
Revenue308.00K
Gross Profit308.00K
Operating Income-102.69M
Pretax Income-150.41M
Net Income-149.27M
EBITDA-144.81M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -79.49M and capital expenditures -89.00K, giving a free cash flow of -79.58M billion.
Operating Cash Flow-79.49M
Free Cash Flow-79.58M
Free Cash Flow per Share-0.22
Dividends & Yields
ATAI Life Sciences pays an annual dividend of $6, resulting in a dividend yield of ―
Dividend Per Share$6
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change139.52%
50-Day Moving Average5.20
200-Day Moving Average3.09
Relative Strength Index (RSI)31.24
Average Volume (3m)6.51M
Important Dates
ATAI Life Sciences upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend DateAug 27, 2018
Financial Position
ATAI Life Sciences as a current ratio of 3.21, with Debt / Equity ratio of 1.85%
Current Ratio3.21
Quick Ratio3.21
Debt to Market Cap0.11
Net Debt to EBITDA-0.05
Interest Coverage Ratio-32.87
Taxes
In the past 12 months, ATAI Life Sciences has paid -356.00K in taxes.
Income Tax-356.00K
Effective Tax Rate<0.01
Enterprise Valuation
ATAI Life Sciences EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -2.67.
EV to Sales714.98
EV to EBITDA-1.52
EV to Free Cash Flow-2.67
EV to Operating Cash Flow-2.67
Balance Sheet
ATAI Life Sciences has $30.40M in cash and marketable securities with $2.96M in debt, giving a net cash position of $27.44M billion.
Cash & Marketable Securities$30.40M
Total Debt$2.96M
Net Cash$27.44M
Net Cash Per Share$0.08
Tangible Book Value Per Share$0.71
Margins
Gross margin is 75.18%, with operating margin of -33341.23%, and net profit margin of -48463.96%.
Gross Margin75.18%
Operating Margin-33341.23%
Pretax Margin-48832.79%
Net Profit Margin-48463.96%
EBITDA Margin-47186.04%
EBIT Margin-47169.16%
Analyst Forecast
The average price target for ATAI Life Sciences is $12.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.71
Price Target Upside217.75% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast―